These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27709629)

  • 1. Development of hepatocellular carcinoma in chronic hepatitis B patients with advanced fibrosis is independent of viral genotype.
    Kumar R; Testoni B; Fresquet J; Lim TK; Hao Y; Tan HH; Chow WC; Zoulim F
    J Med Virol; 2017 May; 89(5):845-848. PubMed ID: 27709629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can quantitative hepatitis B surface antigen levels predict the severity of liver disease in genotype E Patients?
    Chakrabarty G; Bruce M; Horner M; Wang B; Agarwal K; Carey I
    J Viral Hepat; 2018 Jan; 25(1):80-87. PubMed ID: 28710798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of development of hepatocellular carcinoma in Japanese patients infected with hepatitis B virus is equivalent between genotype B and C in long term.
    Haga H; Saito T; Okumoto K; Tomita K; Katsumi T; Mizuno K; Nishina T; Watanabe H; Ueno Y
    J Viral Hepat; 2019 Jul; 26(7):866-872. PubMed ID: 30924226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
    Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
    Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virological outcomes in patients infected chronically with hepatitis B virus genotype A in comparison with genotypes B and C.
    Kobayashi M; Akuta N; Suzuki F; Suzuki Y; Arase Y; Ikeda K; Hosaka T; Saitoh S; Kobayashi M; Someya T; Sato J; Watabiki S; Miyakawa Y; Kumada H
    J Med Virol; 2006 Jan; 78(1):60-7. PubMed ID: 16299721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.
    Chan HL; Hui AY; Wong ML; Tse AM; Hung LC; Wong VW; Sung JJ
    Gut; 2004 Oct; 53(10):1494-8. PubMed ID: 15361502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
    Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
    Tseng TC; Liu CJ; Hsu CY; Hong CM; Su TH; Yang WT; Chen CL; Yang HC; Huang YT; Fang-Tzu Kuo S; Liu CH; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2019 Dec; 157(6):1518-1529.e3. PubMed ID: 31470004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification for hepatitis B virus related hepatocellular carcinoma.
    Lin CL; Kao JH
    J Gastroenterol Hepatol; 2013 Jan; 28(1):10-7. PubMed ID: 23094699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.
    Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1842-8. PubMed ID: 23829381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.
    Yuen MF; Wong DK; Sablon E; Tse E; Ng IO; Yuan HJ; Siu CW; Sander TJ; Bourne EJ; Hall JG; Condreay LD; Lai CL
    Hepatology; 2004 Jun; 39(6):1694-701. PubMed ID: 15185311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent.
    Thakur V; Guptan RC; Kazim SN; Malhotra V; Sarin SK
    J Gastroenterol Hepatol; 2002 Feb; 17(2):165-70. PubMed ID: 11966946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
    Chan HL; Tse CH; Mo F; Koh J; Wong VW; Wong GL; Lam Chan S; Yeo W; Sung JJ; Mok TS
    J Clin Oncol; 2008 Jan; 26(2):177-82. PubMed ID: 18182659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naïve patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma.
    Wang M; Qiu N; Lu S; Xiu D; Yu J; Wang XT; Lu F; Li T; Liu X; Zhuang H
    J Med Virol; 2013 Feb; 85(2):219-27. PubMed ID: 23168998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum hepatitis B surface antigen correlates with tissue covalently closed circular DNA in patients with hepatitis B-associated hepatocellular carcinoma.
    Wang Q; Luan W; Warren L; Fiel MI; Blank S; Kadri H; Tuvin D; Hiotis SP
    J Med Virol; 2016 Feb; 88(2):244-51. PubMed ID: 26174662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct distribution pattern of hepatitis B virus genotype C and D in liver tissue and serum of dual genotype infected liver cirrhosis and hepatocellular carcinoma patients.
    Datta S; Roychoudhury S; Ghosh A; Dasgupta D; Ghosh A; Chakraborty BC; Ray S; Gupta S; Santra AK; Datta S; Das K; Dhali GK; Chowdhury A; Banerjee S
    PLoS One; 2014; 9(7):e102573. PubMed ID: 25032957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection.
    Kannangai R; Molmenti E; Arrazola L; Klein A; Choti M; Thomas DL; Torbenson M
    J Viral Hepat; 2004 Jul; 11(4):297-301. PubMed ID: 15230851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different pre-S deletion patterns and their association with hepatitis B virus genotypes.
    Chen BF
    World J Gastroenterol; 2016 Sep; 22(35):8041-9. PubMed ID: 27672298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.